Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)

Market Cap	32.04B -23.1%
Revenue (ttm)	78.46B +5.3%
Net Income	2.95B +9.1%
EPS	1.81 +9.2%
Shares Out	1.63B
PE Ratio	11.47
Forward PE	10.77
Dividend	0.90 (4.26%)
Ex-Dividend Date	Jun 16, 2026

Volume	5,600,900
Open	21.08
Previous Close	21.11
Day's Range	20.75 - 21.08
52-Week Range	20.77 - 27.85
Beta	0.24
Analysts	Hold
Price Target	25.80 (+24.16%)
Earnings Date	Aug 14, 2026

About SHA:600332

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People’s Republic of China and internationally. The company operates through Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Business, Pharmaceutical Commercial Business, and Other segments. It is involved in the research, development, manufacturing, and sale of chemical drugs, chemical raw materials, and chemical raw material intermediates; and research, development, productio...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1997
• Employees: 27,057
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600332

Financial Performance

In 2025, SHA:600332's revenue was 77.66 billion, an increase of 3.55% compared to the previous year's 74.99 billion. Earnings were 2.98 billion, an increase of 5.21%.

Analyst Summary

According to 2 analysts, the average rating for 600332 stock is "Hold." The 12-month stock price target is ¥25.80, which is an increase of 24.16% from the latest price.

Price Target

¥25.80

(24.16% upside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 18, 2026

Data Sources Report a data error